Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Brain : a Journal of Neurology|November 18, 2011
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunityMireia Guerau-de-Arellano, Kristen M Smith, Jakub Godlewski, et al.Therapeutic Advances in Neurological Disorders|December 25, 2010
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS)Gina M Remington, Katherine Treadaway, Teresa Frohman, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune diseaseAmy E Lovett-Racke, Rehana Z Hussain, Sara Northrop, et al.The Journal of Experimental Medicine|June 24, 2009
T-bet is essential for encephalitogenicity of both Th1 and Th17 cellsYuhong Yang, Jeffrey Weiner, Yue Liu, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune diseaseAnne R Gocke, Rehana Z Hussain, Yuhong Yang, et al.Plos One|January 8, 2009
PEG minocycline-liposomes ameliorate CNS autoimmune diseaseWei Hu, Josbert Metselaar, Li-Hong Ben, et al.Neurology. Clinical Practice|October 10, 2025
Development and Clinical Validation of Blood-Based Multibiomarker Models for the Evaluation of Brain Amyloid PathologyDarren M Weber, Matthew A Stroh, Steven W Taylor, et al.Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Development and clinical validation of blood-based multibiomarker models for the evaluation of brain amyloid pathologyDarren M Weber, Matthew A Stroh, Steven W Taylor, et al.JCI Insight|January 7, 2021
A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balanceSaba I Aqel, Xiaozhi Yang, Emma E Kraus, et al.Brain : a Journal of Neurology|May 19, 2016
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosisMary E Severin, Priscilla W Lee, Yue Liu, et al.Pageof 12